Browsing: Portfolio

The move broadens the company’s offering beyond phosphates and marks a further step in strengthening its position as a long-term strategic partner to the dietary supplement industry. The addition of chelated minerals marks a further step in the evolution of Budenheim’s Life Science portfolio. The initial Budal Plus portfolio comprises magnesium bisglycinate, ferrous bisglycinate HCl and…